References
- Israel L, Breau JL, Aguilera J. High-dose cyclophosphamide and high-dose 5-fluorouracil. A new first-line regimen for advanced breast cancer. Cancer 1984; 53: 1655–1659
- Merrin C. Preliminary report on combination therapy for advanced prostatic cancer. Cancer Treat Rep 1977; 61: 313–315
- Lavin P, Mittlernan A, Douglass H, Jr, et al. Survival and response to Chemotherapy for advanced colorectal carcinoma. Cancer 1980; 46: 1536–1543
- Chlebowski R, Gota C, Glass A, et al. Combination chemotherapy with cyclophosphamide plus 5-fluorouracil for treatment of unresectable pancreatic adenocarcinoma. Cancer Treat Rep 1979; 63: 2119–2121
- Izbicki RM, Baker LH, Samson MK, et al. 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer. Cancer Treat Rep 1977; 61: 1573–1575
- Shabel F, Jr. Animal models as predictive systems. Cancer Chemotherapy: Fundamental Concepts and Recent Advances. Year Book Medical Publishers, Chicago 1975; 323–355
- Kanzawa F, Hoshi A, Kuretani K. Interaction of antitumor agents in sarcoma-180 system. Gann 1974; 65: 55–60
- Mutz I, Coulter D, Vietti T. Studies on the combination of 5-FU and alkylating agents. Proc AACR 1977; 18: 149
- Fernandes DJ, Klubes P. A biochemical and pharmacological study of therapeutic synergism with 5-fluomuracil plus cyclophosphamide in murine L1210 leukemia. Cancer Res 1979; 39: 1396–1404
- Mulder JH, Smink T, Ossewaarde T, et al. Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy. Eur J Cancer 1980; 16: 699–705
- Santelli G, Valeriote F, Vietti T, et al. Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against tramplantable leukemias. Eur J Cancer 1981; 17: 629–634
- Grossie VB, Jr, Rosenblum MG, Loo TL. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia. Cancer Treat Rep 1982; 66: 1631–1634
- Carter WH, Jr, Wampler GL, Stablein DM. Regression analysis of survival data in cancer chemotherapy. Statistics: Textbooks and Monographs, DB. Owen, RC. Cornell. Marcel Dek-ker, New York and Basel 1983; 137, 166–206
- Eaves AC, Bruce WR. Altered sensitivity of hematopoietic stem cells to 5-fluorouracil (NSC-19893) following endotoxin (NSC-189681), cyclophosphamide (NSC-26271) or irradiation. Cancer Chemother Rep 1974; 58: 813–820
- Cox DR. Regression models and life tables?. JR Stat Soc B. 1972; 34: 187–220
- Nelder JA, Mead RA. A simplex method for function minimization. Comput J 1965; 7: 308–313
- Carter WH, Jr, Wampler GL, Stablein DM, et al. Drug activity and therapeutic synergism in cancer treatment. Cancer Res 1982; 42: 2963–2971